Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastoma.

Zahra MotahariJavier J LepeMalia R BautistaClay HoerigAshley S Plant-FoxBhaskar DasChristie D FowlerSuresh N MaggeDaniela A Bota

Published in: bioRxiv : the preprint server for biology (2024)

data showed BT9 antitumor efficacy in DAOY and D425 cell lines suggesting that BT9 may represent a promising targeted therapeutic in pediatric medulloblastoma. These data, however, need to be further validated in animal models.

Keyphrases

electronic health record
big data
machine learning
cell therapy
risk assessment
mesenchymal stem cells
young adults
human health
deep learning